Abstracts tagged "qualitative and spondylarthritis"

Abstract Number: 1196 • 2015 ACR/ARHP Annual Meeting
Patient Education in Spondyloarthritis Should be Guiding, Reliable and Available and Presented in Varied Formats
Emma Haglund^1,2,3, Ann Bremander^1,2,3, Stefan Bergman^1,3,4 and Ingrid Larsson^3,5, ¹Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Lund, Sweden, ²School of Business, Engineering and Science, Halmstad University, Halmstad, Sweden, ³Spenshult Research and Development Center, Halmstad, Sweden, ⁴Primary Health Care Unit, Department of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, ⁵School of Health and Welfare, Halmstad University, Halmstad, Sweden
Background/Purpose: The treatment target for axial spondyloarthritis (SpA) is to maximize health-related quality of life (HRQoL) by controlling disease activity and improving functioning. The treatment…
Abstract Number: 3234 • 2015 ACR/ARHP Annual Meeting
Roadblocks Perceived By Canadian Dermatologists for Referring Patients with Suspected Psoriatic Arthritis
Renise Ayearst¹, Daniel Pereira¹, Charles Lynde², Holly Etchegary³ and Vinod Chandran¹, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Memorial University of Newfoundland, St.John's, NF, Canada
Background/Purpose: The current system of referral by Canadian dermatologists of patients who may have psoriatic arthritis (PsA) to rheumatologists is suboptimal. Hypothesizing that knowledge level,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].